News
Blood clots are a silent threat behind many serious illnesses—from sepsis and cancer to viral infections and autoimmune disease. Now, inventors at the NIH National Cancer Institute (NCI) have identified a promising new way to stop dangerous clots before they spiral out of control, without increasing
Louis Staudt, M.D., Ph.D. was recently awarded the Career Achievement Award, which recognizes ten or more years in HHS and dedication and loyalty to the Department. Dr. Staudt is the Chief of the Lymphoid Malignancies Branch at NCI. Dr. Staudt pioneered the use of gene expression profiling to
The National Institute of Dental and Craniofacial Research (NIDCR) at the NIH has a great non-exclusive license opportunity available to commercialize a novel adeno-associated virus termed “44-9” (AAV44-9) vector for gene therapy. AAV44-9 based vectors have high gene transfer activity in many cell
Attend the FLC’s Using Valuations in Technology Transfer webinar to hear from NIH Office of Technology Transfer’s (OTT’s) Steve Ferguson on why using valuations is a good start to gathering information needed at various stages of technology transfer. Topics covered include why valuation is needed